BACK TO CONTENTS   |    PDF   |   


Title

Molecular docking based design of Dengue NS5 methyltransferase inhibitors

 

Authors

Mohd Adnan Kausar1,*, Abrar Ali1, Samir Qiblawi1, SMA Shahid1, Mohammad Asrar Izhari2 & Anamika Saral3

 

Affiliation

1College of Medicine, University of Hail, Hail, KSA; 2Department of Laboratory Medicine College of Applied Medical Science, Al-Baha University, Saudi Arabia; 3School of studies in Biotechnology, Jiwaji University, Gwalior, Madhya Pradesh, India.

 

Email

Mohd Adnan Kausar - Email: adnankausar1@gmail.com; *Corresponding author

 

Article Type

Research Article

 

Date

Received April 17, 2019; Accepted April 23, 2019; Published May 30, 2019

 

Abstract

Dengue is a viral infection caused by RNA infection of the family Flaviviridae and spread by the Aedes mosquitoes. Dengue NS5 methyltransferase is a known drug target for the disease. Therefore, it is of interest to design potential inhibitors for the target using molecular docking analysis. Our analysis shows the binding of compounds STOCK1N-98943, STOCK1N-98872, STOCK1N-98956, STOCK1N-98865, and STOCK1N-98950 with the protein drug target with optimal binding features for further in vitro and in vivo evaluations.

 

Keywords

Dengue, methyltransferase, molecular docking, virtual Screening and IBS.

 

Citation

Kausar et al. Bioinformation 15(6): 394-401 (2019)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.